Jing-Houng Wang

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Peritoneal Dialysis

Hepatitis C Virus

Palliative Care

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

The Kaohsiung journal of medical sciences

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Jing-Houng Wang, Hsin-You Ou, Yi-Hao Yen, Chao-Hung Hung, Sheng-Nan Lu
Usefulness of controlled attenuation parameter in monitoring clinically relevant decline of hepatic steatosis for non-alcoholic fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver (2023)
Yuan-Hung Kuo, Kwong-Ming Kee, Chao-Hung Hung, Sheng-Nan Lu, Tsung-Hui Hu, Chien-Hung Chen, Jing-Houng Wang
Liver stiffness-based score at sustained virologic response predicts liver-related complications after eradication of hepatitis C virus. The Kaohsiung journal of medical sciences (2021)
Tsung-Hui Hu, Sherry Yueh-Hsia Chiu, Po-Lin Tseng, Chien-Hung Chen, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Kwong-Ming Kee, Ming-Tsung Lin, Kuo-Chin Chang, Meng-Chih Lin, Rong-Nan Chien
Five-year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment-naïve patients with chronic hepatitis B-related compensated cirrhosis in Taiwan. Alimentary pharmacology & therapeutics 52 (11-12) (2020)
Hung-Hsien Chiang, Chuan-Mo Lee, Tsung-Hui Hu, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu, Hsueh-Chou Lai, Wen-Pang Su, Chia-Hsin Lin, Cheng-Yuan Peng, Chien-Hung Chen
A combination of the on-treatment FIB-4 and alpha-foetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavir. Liver international : official journal of the International Association for the Study of the Liver 38 (11) (2018)